COX-2 Expression in Oral Lichen Planus

Oral lichen planus (OLP) is a chronic inflammatory disease of unknown cause, which possesses the potential for malignant transformation. Cyclooxygenases (COX) 1 and 2 are two enzymes known to convert arachidonic acid into prostaglandins. Recent studies have shown an overexpression of COX-2 in oral squamous cell carcinoma and its precursor lesions. The present study investigated the expression of the COX-2 protein in OLP by Western blot analysis. Thirty patients with different degrees of histologically confirmed disease activity participated in the study: 9 patients had a recent onset of active OLP, 12 patients had atrophic OLP with moderate or low activity, and 9 patients presented with atrophic OLP with complete loss of activity. The results showed a high expression of COX-2 in all OLP patients in comparison with the control group. The differences in COX-2 expression in the various stages of OLP were not statistically significant. In conclusion, our results suggest that COX-2 is present during the various clinical forms of OLP. The resulting sustained overexpression of COX-2 in the late stage of the disease could play a role in the malignant transformation of some OLP.

[1]  K. Lončarek,et al.  From Shape to Pathogenesis: Fractal Formation of Lichen Planus , 2007, Dermatology.

[2]  E. Neppelberg,et al.  DNA content, Cyclooxygenase-2 expression and loss of E-cadherin expression do not predict risk of malignant transformation in oral lichen planus , 2007, European Archives of Oto-Rhino-Laryngology.

[3]  J. Sudbø,et al.  Retraction notice to 'Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions' [Oral Oncol. 39 (2003) 497-505]. , 2007, Oral oncology.

[4]  Zhi Wang,et al.  Chemopreventive Effect of Celecoxib in Oral Precancers and Cancers , 2006, The Laryngoscope.

[5]  B. Sjöström,et al.  Expression of p63, COX-2, EGFR and beta-catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non-neoplastic tissue and no obvious changes in smokers. , 2005, International journal of oncology.

[6]  P. Sugerman,et al.  Current controversies in oral lichen planus: report of an international consensus meeting. Part 2. Clinical management and malignant transformation. , 2005, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[7]  P. Sugerman,et al.  Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis. , 2005, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[8]  M. Osaki,et al.  Cyclo-oxygenase-1 and -2 expression in human oral mucosa, dysplasias and squamous cell carcinomas and their pathological significance. , 2005, Oral oncology.

[9]  N. Altorki,et al.  Levels of cyclooxygenase-2 are increased in the oral mucosa of smokers: evidence for the role of epidermal growth factor receptor and its ligands. , 2005, Cancer research.

[10]  N. Nishikawa,et al.  Cyclooxygenase‐2 is a possible target of treatment approach in conjunction with photodynamic therapy for various disorders in skin and oral cavity , 2004, The British journal of dermatology.

[11]  S. Fedele,et al.  Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence ? , 2004, Oral oncology.

[12]  Y. Takano,et al.  Immunohistochemical study on overexpression of cyclooxygenase-2 in squamous cell carcinoma of the oral cavity: its importance as a prognostic predictor. , 2003, Oral oncology.

[13]  T. Lombardi,et al.  Erosion and Ulceration Occurring on Oral Lichen planus. Comments on the Article ‘Erosive Lichen planus: What Is This? by A. Rebora , 2003, Dermatology.

[14]  H. Kuniyasu,et al.  Inhibitory effects of selective cyclooxygenase-2 inhibitors, nimesulide and etodolac, on the development of squamous cell dysplasias and carcinomas of the tongue in rats initiated with 4-nitroquinoline 1-oxide. , 2003, Cancer letters.

[15]  J. Epstein,et al.  Carcinogenesis and cyclooxygenase: the potential role of COX-2 inhibition in upper aerodigestive tract cancer. , 2003, Oral oncology.

[16]  K. Schepman,et al.  The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective study. , 2003, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[17]  J. Sudbø,et al.  Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions. , 2003, Oral oncology.

[18]  T. Axéll,et al.  Erythematous and reticular forms of oral lichen planus and oral lichenoid reactions differ in pathological features related to disease activity. , 2003, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[19]  J. Vishwanatha,et al.  Deregulated cyclooxygenase-2 expression in oral premalignant tissues. , 2002, Molecular cancer therapeutics.

[20]  N. V. Chandrasekharan,et al.  COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Jontell,et al.  Oral lichen planus and malignant transformation: is a recall of patients justified? , 2002, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[22]  J. Roh,et al.  Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs. , 2002, Anticancer research.

[23]  P. Sugerman,et al.  The Pathogenesis of Oral Lichen Planus on Behalf Of: International and American Associations for Dental Research , 2002 .

[24]  T. Paavonen,et al.  Expression of cyclo-oxygenase-2 in human tongue carcinoma and its precursor lesions , 2002, Virchows Archiv.

[25]  J. Masferrer,et al.  Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. , 2002, Cancer research.

[26]  R. Shi,et al.  COX‐2 expression in dysplasia of the head and neck , 2001 .

[27]  E. Eisenberg,et al.  Oral lichen planus: a benign lesion. , 2000, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[28]  Y. Doki,et al.  Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[29]  Li Zhu,et al.  Specific Inhibition of Cyclooxygenase 2 Restores Antitumor Reactivity by Altering the Balance of IL-10 and IL-12 Synthesis1 , 2000, The Journal of Immunology.

[30]  M. Malmström,et al.  A retrospective study of oral lichen planus patients with concurrent or subsequent development of malignancy. , 1999, Oral oncology.

[31]  J. Shah,et al.  Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. , 1999, Cancer research.

[32]  A. Ristimäki,et al.  Expression of cyclooxygenase-2 in human lung carcinoma. , 1998, Cancer research.

[33]  M. Rosin,et al.  Molecular analysis of oral lichen planus. A premalignant lesion? , 1997, The American journal of pathology.

[34]  R. Coffey,et al.  Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. , 1994, Gastroenterology.

[35]  S. Cunningham,et al.  Oral cancer development in patients with oral lichen planus. , 1993, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[36]  T. Axéll,et al.  Oral lichen planus--a demographic study. , 1987, Community dentistry and oral epidemiology.

[37]  C. Tsatsanis,et al.  Signalling networks regulating cyclooxygenase-2. , 2006, The international journal of biochemistry & cell biology.

[38]  Quan-hong Wang,et al.  Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey. , 1999, Anticancer research.

[39]  C. Scully,et al.  Update on oral lichen planus: etiopathogenesis and management. , 1998, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[40]  J. Pindborg,et al.  Erythroplakic lesions in relation to oral lichen planus. , 1979, Acta dermato-venereologica. Supplementum.

[41]  J. Andreasen,et al.  Oral lichen planus: I. A clinical evaluation of 115 cases , 1968 .